3/26/2024Anti-China Bills Portend Massive Blow to Biotech: BioCentury Survey (B...

3/26/2024China Plays Down Concerns Over State Health Insurance Scheme, But Ques...

3/25/2024Lilly CEO Reaffirms Commitment to Chinese Market amid US Threat agains...

3/25/2024China Unveils Plans for Market Access and Data Regulation Overhaul

3/22/2024Recent Official and Executive Moves

3/21/2024U.S. Biz Leaders Including Pharma CEOs Set to Meet Chinese President X...

3/21/2024NHC Unveils Ambitious Plan to Elevate Healthcare System

3/20/2024WuXi Biologics Breaks Ground on State-of-the-Art $1.4 Billion CRDMO Fa...

3/20/2024WuXi XDC Builds Singapore Manufacturing Facility for Global Bioconjuga...

3/20/2024China Ranked Top Potential Biopharma Outsourcing Destination (Bioproce...

3/19/2024Perspectives on 2024's Two Sessions (NCUSCR)

3/19/2024China to Expand Pilot Program for Medical Services Pricing Reform

3/19/2024NDRC Issues 2024 Edition of the Guiding Catalog for Adjustment of Indu...

3/19/2024Novo Nordisk Invests CNY 4B Into Flagship Tianjin Plant Expansion Ahea...

3/19/2024China Issues New Document on Advancing Physician Electronic Informatio...

3/18/2024Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars...

3/18/2024The US and Chinese Biopharma Contractors (Science)

3/15/2024Chinese Pharma Stocks Surge amid Speculation of Government Support for...

3/15/2024Recent Executive Moves

3/14/2024Sinohealth: Review of Chinese Retail Pharmacy Drug Sales and Top 20 Pr...

3/14/2024PhIIC: Review of Prescription Drug Sales Trends in Chinese Retail Phar...

3/13/2024IQVIA: Chinese Hospital Drug Market Rose 4.2% in 2023 (MAT Q4/2023)

3/13/2024Biotech Lobby Group BIO to Sever Ties with WuXi Amid National Security...

3/13/2024WuXi Became a Critical Partner to Biopharma Companies. They're Not Rea...

3/13/2024Navigating China's Biologics Approval And Accelerated Pathways (Clinic...

3/12/2024Global Pharmaceutical Investment in Asia: A Strategic Focus Amidst Evo...

3/12/2024BIO Faces Criticism for Involvement in Legislation Concerning China's ...

3/11/2024Johnson & Johnson Completes Acquisition of Ambrx

3/10/2024China Biopharma Tracker – February 2024 (PharmaNJ)

3/8/2024Recent Official Changes and Executive Moves

Page:42/367 Total number of articles:10993: [First][<<] [40] [41] [42] [43] [44] [>>] [End]